Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2023-10-02 00:00:00 ET · period of report 2023-09-28 · accession 0001628280-23-033520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-02 | 2023-09-28 | ARWR | Vakiener Victoria | Dir | S - Sale | $26.33 | -1,550 | 21.7K | -7% | -$40.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-28 | S | D | 1,550 | $26.33 | 21,734 | D | — | — | (F1) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |